长风药业股份有限公司(02652)于2026年5月27日发布翌日披露报表，公告显示公司于当日在香港联交所场内购回3.75万股股份，约占此前已发行股本的0.0125%。
购回价格介乎每股19.49港元至20.38港元，合计付出约73.87万港元。回购后，公司已发行股本减少至301117586股，库藏股则增至1106000股，总股本维持302223586股不变。公告同时披露，回购授权于2025年12月16日获股东大会通过，总回购上限为30222358股。截至目前，基于该授权已在联交所或其他证券交易所累计回购1106000股，占授权通过当日已发行股本约0.366%。
公司在公告中确认，已遵守香港联交所上市规则及相关法律法规。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.